Patents Assigned to Cytopia Pty Ltd
  • Pyrazine-based tubulin inhibitors
    Publication number: 20070082894
    Abstract: A compound of general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating a hyperproliferation-related disease state or disorder in a subject using a compound of formula (I) is also described.
    Type: Application
    Filed: December 11, 2003
    Publication date: April 12, 2007
    Applicant: Cytopia Pty Ltd
    Inventors: Christopher Burns, Andrew Wilks, Xianyong Bu, Harrison Sikanyika, Michael Harte
  • Nicotinamide-based kinase inhibitors
    Publication number: 20070060619
    Abstract: A compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating tyrosine kinase-associated disease states in a subject using a compound of formula (I) is also described.
    Type: Application
    Filed: December 15, 2003
    Publication date: March 15, 2007
    Applicant: CYTOPIA PTY LTD
    Inventors: Christopher Burns, Marcel Kling
  • Protein kinase inhibitors
    Patent number: 7122550
    Abstract: A compound of the general formula: or pharmaceutically acceptable salts, hydrates, solvates, crystal forms of diastereomers thereof is described. A method of treating protein kinase-associated disease states using the compound of Formula I is also described.
    Type: Grant
    Filed: May 23, 2003
    Date of Patent: October 17, 2006
    Assignee: Cytopia Pty Ltd
    Inventors: Christopher John Burns, Xianyong Bu, Andrew Frederick Wilks